Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol in Diabetes and Multivessel CAD
NCT03700645Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of allopurinol in coronary artery disease (CAD), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
allopurinol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03700645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700645.